Skip to content

Tyler Francis Aguinaldo, MD

NPI 1306811906ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Burlingame, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Burlingame, California, trained at University of California, San Diego School of Medicine (class of 1999). Their prescriptions cost Medicare Part D more than their services did: $1,262,914 for 2,581 claims, against $104,507 paid for services in 2024. Sanofi-Aventis U.S. LLC was the largest of 4 companies reporting payments in 2025, $454.54 in all, mostly food and beverage.

Overview

NPI1306811906
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedFeb 17, 2006
Last updated in NPPESJun 22, 2020
Certified by providerJun 22, 2020

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients330
Services billed1,298 across 18 procedure codes
Paid by Medicare$104,507

Part D prescriptions in 2024

Prescriptions (claims)2,581 · 6,679 30-day fills
Patients356
Total drug cost$1,262,914
Generic share41% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of California, San Diego School of Medicine
Graduation year1999
Medicare specialtyEndocrinology
Secondary specialtiesInternal Medicine
TelehealthOffers telehealth

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$454.54 · 5 payments from 4 companies
  • 2024$163.68 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Sanofi-Aventis U.S. LLC$235.642
Novo Nordisk Inc$124.441
Sequel Med Tech, LLC$73.711
Dexcom, Inc.$20.751

What the 2025 payments were for

  • Food and Beverage$454.54 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Burlingame

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →